The Therapeutic Potential of Vascular Adhesion Protein-1 in Primary Sclerosing Cholangitis

Medicine & Life Sciences

1. Sclerosing Cholangitis 100%
2. Biliary Liver Cirrhosis 94%
3. Digestive System Diseases 85%
4. Immunogenetics 83%
5. Immune Tolerance 76%
6. Cholestasis 71%
7. Chemokine Receptors 70%
8. Major Histocompatibility Complex 64%
9. Genetic Predisposition to Disease 64%
10. Inflammatory Bowel Diseases 59%
11. Chemokines 59%
12. Liver Transplantation 57%
13. Autoimmune Diseases 54%
14. Liver Diseases 53%
15. Mortality 39%
16. Liver 32%
17. CC chemokine receptor 9 29%
18. CXCR3 Receptors 25%
19. Therapeutics 23%
20. Ligands 22%
21. Ursodeoxycholic Acid 20%
22. Clinical Trials 20%
23. Mucosal Immunity 19%
24. Enterocytes 18%
25. Liver Cirrhosis 14%
26. Risk Assessment 13%
27. Patient Care 12%
28. Cohort Studies 10%
29. Quality of Life 10%
30. Morbidity 9%
31. Incidence 7%
32. Wounds and Injuries 7%